AU Stock MarketDetailed Quotes
DXBO Dimerix Ltd
- 0.250
- +0.020+8.70%
20min DelayMarket Closed May 17 16:00 AET
137.42MMarket Cap0.00P/E (Static)
0.250High0.235Low149.27KVolume0.235Open0.230Pre Close36.07KTurnover0.25552wk High0.04%Turnover Ratio549.67MShares0.01552wk Low--EPS TTM99.64MFloat Cap0.255Historical High0.00P/E (Static)398.57MShs Float0.015Historical Low--EPS LYR6.52%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
About Dimerix Ltd Company
Dimerix Ltd is a biopharmaceutical company developing innovative new therapies in areas with unmet medical needs. The company is developing five product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for COVID-19 pneumonia patients in ICU; DMX-200 for respiratory complications in Covid-19 patients; and DMX-700 for COPD; as well as the proprietary ReceptorHIT assay technology.
Company Profile
SymbolDXBO
Company NameDimerix Ltd
Founded1975
MarketASX
Employees9
Fiscal Year Ends06-30
Address425 Smith Street
CityFitzroy
CountryAustralia
Zip Code3065
Phone+61 1300813321
Websitehttps://www.dimerix.com
Company Executives
- Name
- Position
- Salary
- Nina Webster
- Chief Executive Officer,Managing Director
- --
- Sonia Maria Poli
- Non-Executive Director
- --
- Hugh Alsop
- Non-Executive Director
- --
- Clinton Snow
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg